'Ii trial' diaporamas de présentation

Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer

Emerging Paradigms in the Multimodality Treatment of Locally Advanced Rectal Cancer. A. William Blackstock, Jr., MD Wake Forest University Comprehensive Cancer Center. Case Presentation. A 56 year old gentleman presents with several weeks of Hematochezia and 15 lbs weight loss

718 views • 40 slides

Azacitidine in AML/MDS after allogeneic HSCT

Azacitidine in AML/MDS after allogeneic HSCT. ????????? ??? / ?????. Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative treatment in patients with advanced myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)

788 views • 29 slides

Bashi Ratterree, RN, BSN, CCRP

Bashi Ratterree, RN, BSN, CCRP Nurse Coordinator, CHM OHSU Knight Cancer Institute Mail code: UHN73C 503-494-9982 ratterre@ohsu.edu. A Phase II Trial of the Safety and Efficacy of Abc-001 for the Treatment of CoordinatorStressitis. Adverse Events Reporting Exercise. 2 yr trial

384 views • 21 slides

Memorial Sloan-Kettering Cancer Center, New York, NY

Adjuvant gemcitabine plus docetaxel for completely resected stage I-IV high grade uterine leiomyosarcoma: results of a phase II trial. Martee L. Hensley, Nicole Ishill, Robert Soslow, Nadeem Abu-Rustum, Paul Sabbatini, Jason Konner, William Tew, David Spriggs, Carol A. Aghajanian.

375 views • 21 slides

1 Nowakowski GS et al. Proc ASH 2012;Abstract 689.

270 views • 18 slides

Richardson PG et al. Proc ASH 2013;Abstract 535.

Twice-Weekly Oral MLN9708 (Ixazomib Citrate), an Investigational Proteasome Inhibitor, in Combination with Lenalidomide (Len) and Dexamethasone (Dex) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (MM): Final Phase 1 Results and Phase 2 Data. Richardson PG et al.

290 views • 13 slides

Heinrich & Corless Laboratories GIST Research Updates: May 2011

180 views • 12 slides

1 Touzeau C et al. Proc ASCO 2013;Abstract 8513.

184 views • 11 slides

HIV Vaccine Research & Development

260 views • 11 slides

ARTS-II Trial

ARTS-II Trial. Arterial Revascularization Therapies Part II: a non-randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery lesions. Presented at The American College of Cardiology 2005. ARTS-II Trial.

361 views • 6 slides

BMT CTN 0302 Randomized Phase II Trial of Four Acute GVHD Therapies

HCT (BM, PBSC, CB). Acute GVHD (diagnosed in past 48 hours). Yes, requiring systemic therapy. No. RANDOMIZATION. Prednisone, and Etanercept , or MMF*, or Ontak, or Pentostatin . If progressive GVHD within 7 days, or no response within 14 days, treat

342 views • 1 slides